Loading...
XJPX
4540
Market cap1.74bUSD
Jul 10, Last price  
3,820.00JPY
1D
0.53%
1Q
1.08%
Jan 2017
18.63%
Name

Tsumura & Co

Chart & Performance

D1W1MN
XJPX:4540 chart
P/E
10.13
P/S
1.48
EPS
377.18
Div Yield, %
3.58%
Shrs. gr., 5y
-0.47%
Rev. gr., 5y
8.03%
Revenues
192.62b
+6.36%
91,252,000,00094,804,000,00090,027,000,00090,933,000,00094,778,000,00095,451,000,000105,638,000,000110,057,000,000110,438,000,000112,625,000,000114,954,000,000117,879,000,000120,906,000,000123,248,000,000130,883,000,000129,546,000,000140,043,000,000150,845,000,000181,093,000,000192,615,000,000
Net income
28.12b
-13.29%
13,152,000,0009,139,000,00010,777,000,00010,704,000,00012,945,000,00013,431,000,00015,373,000,00018,050,000,00014,075,000,00012,557,000,00012,488,000,00014,504,000,00014,593,000,00013,765,000,00015,332,000,00018,836,000,00016,482,000,00016,707,000,00032,428,000,00028,117,000,000
CFO
24.72b
-26.92%
12,687,000,0005,358,000,00010,634,000,00012,019,000,00012,047,000,0007,314,000,00012,011,000,0005,908,000,0004,993,000,00017,570,000,00021,065,000,00021,066,000,0005,450,000,00018,191,000,00016,102,000,00021,314,000,00016,452,000,0005,608,000,00033,823,000,00024,718,000,000
Dividend
Sep 29, 202679 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Established in Tokyo, Japan, in 1893, Tsumura & Co. operates worldwide in the pharmaceutical sector. The company's core business involves the creation and international distribution of various medicinal products, with a particular focus on Kampo extract intermediates and granular Kampo preparations. Its operations are comprehensive, encompassing the full supply chain: from the careful acquisition, selection, processing, and warehousing of raw herbal materials and crude drug components for decoctions, to the manufacturing of powdered Kampo extracts and traditional Chinese medicines. Additionally, Tsumura & Co. is engaged in the sale of both pharmaceutical goods and food products.
URL
https://www.tsumura.co.jp/
IPO date
Nov 21, 1980
Employees
4,032
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT